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Summary 24 
Background: The therapeutic effect and the underlying mechanisms of the helminth species T. 25 
suis, that has shown initially promising results for treatment of inflammatory bowel disease 26 
(IBD) but more recently no benefit  in Crohn’s disease in human studies, cannot be studied in 27 
mice and rats as T. suis fails to colonize the rodent intestine whilst hatching in humans and 28 
rabbits. Since a suitable rabbit IBD model is currently not available, we developed a rabbit 29 
colitis model by administration of dextran sodium sulphate (DSS). 30 
Methods: White Himalayan rabbits (n = 12) received 0.1 % DSS in the daily beverage for 5 31 
days. Clinical symptoms were monitored daily and rabbits were sacrificed at different time 32 
points. A genome wide expression analysis was performed with RNA isolated from cecal 33 
lamina propria mononuclear cells and epithelial cells. 34 
Results: The disease activity index of DSS rabbits increased up to 2.1 ± 0.4 (n = 6) at day 10 35 
(controls < 0.5). DSS induced a cecum localized pathology with crypt architectural distortion, 36 
stunted villous surface and inflammatory infiltrate in the lamina propria. The histopathology 37 
score reached a peak of 14.2 ± 4.9 (n = 4) at day 10 (control animals 7.7 ± 0.9, n = 5). 38 
Expression profiling revealed an enrichment of IBD related genes in both lamina propria 39 
mononuclear cells and intestinal epithelial cells. Innate inflammatory response, Th17 40 
signalling and chemotaxis were among the significantly affected biologically relevant 41 
pathways. 42 
Conclusions: We describe a reproducible and reliable rabbit model of colitis by administration 43 
of DSS. Localization of the inflammation in the cecum and its similarities with IBD make this 44 
model suitable to study T. suis therapy in vivo. 45 
Keywords: rabbit model of inflammatory bowel disease; Crohn's disease; Ulcerative colitis; 46 
DSS colitis; Trichuris suis; RNA sequencing.  47 
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Introduction 48 
Inflammatory bowel diseases (IBD) can be defined as a “post-industrial revolution epidemics” 49 
since their frequency has increased dramatically in the last 60 years (Molodecky, et al., 2012). 50 
Initially, this increase was explained on the basis of the hygiene hypothesis that linked the 51 
improved hygienic conditions and the consequent reduction of childhood-infections with an 52 
increase in the prevalence and incidence of immune-related diseases (Strachan, 1989). Today, 53 
it is assumed that the increase in hygiene standards reduces the interactions with 54 
microorganisms that coevolved with the immune system and influences the balance between 55 
immune-regulatory and effector mechanisms (Rook, 2011). 56 
In 2000, Elliot and colleagues focused their attention on the complementarity between the 57 
distribution of IBD and of helminth infections (Elliott, et al., 2000),(Weinstock, et al., 2002). 58 
In their work, they set the basis for the clinical application of a helminth therapy and proposed 59 
the whipworm parasite Trichuris suis as a therapeutic agent (Summers, et al., 2003). Overall, 60 
the treatment with T. suis ova (TSO) proved to be safe with only mild and transient 61 
gastrointestinal effects reported (Scholmerich, 2013). Those early results for efficacy in IBD 62 
were promising, however, two recent large multicenter trials in mild to moderate Crohn’s 63 
disease with our without immunosuppression could not demonstrate a  significant benefit of 64 
TSO treatment over placebo. Further clinical trials in ulcerative colitis are still under 65 
discussion. a,. So far, most studies have focused on the clinical efficacy and safety and the 66 
mechanisms underlying the TSO treatment effects remain unsolved. The discussion on 67 
whether further clinical studies should be undertaken (i.e. in ulcerative colitis) has given rise 68 
to a request for a better understanding of potential mechanisms and thus establishment of 69 
suitable animal models. 70 
Animal models of colitis are essential for the understanding of the aetiology and 71 
pathophysiology of IBD and constitute an essential tool in the development of new therapies. 72 
Currently, more than 66 different IBD models have been developed in several species 73 
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including mouse, rat, rabbit and tamarin (Wirtz and Neurath, 2000). Generally, IBD models 74 
can be subdivided in four categories of experimental colitis depending on the method of 75 
induction: congenital, genetically engineered, chemically induced, and cell transfer induced 76 
(Mizoguchi, 2012).  77 
Most methods are used successfully in both mouse and rat. Unfortunately, research on the 78 
therapeutic application of T. suis in model organisms is complicated by the unsuccessful 79 
hatching of the ova in the mouse and rat intestine (un-published data). In contrast, the life 80 
cycle of these parasites in the human and rabbit intestine is similar. In both hosts T. suis hatch 81 
and establish in the distal intestine region where the larvae seem to die prematurely without 82 
reaching sexual maturity (un-published data). Therefore, a colitis model in the rabbit would be 83 
a valuable tool to investigate the mechanisms underlying T. suis therapy.  84 
Thus far, the established rabbit IBD models present some drawbacks that limit their use for 85 
translational research. Rectal application of acetic acid causes severe acute inflammation, 86 
ischemia and erosion within one day post application, but fails to induce chronic 87 
inflammation (Hathaway, et al., 1999),(Murthy, 2006). Similarly, trinitrobenzene sulfonic 88 
acid (TNBS) dissolved in ethanol is also applied in the rectum. Within a week after 89 
application, TNBS induces a fully developed inflammation that presents ulcerative lesions 90 
and trans mural inflammation (Anthony, et al., 1995, Anthony, et al., 2007). However, the 91 
development of chronic inflammatory lesions in the TNBS model is highly variable and does 92 
not warrant good reproducibility (Knollmann, et al., 2002). Furthermore, the short-term and 93 
self-limiting nature of these colitis models is poorly adequate to study the relapsing and 94 
remitting course of IBD. Both acetic acid and TNBS are introduced as an enema in the rabbit 95 
rectum and induce an inflammation that is usually confined to the distal colon, whereas T. suis 96 
ova hatch and develop in the ileum and cecum. Further colitis models in rabbits are of limited 97 
use either because of the complicated induction procedure (Hodgson, et al., 1978),(Hotta, et 98 
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al., 1986) or because of the high variability of the induced pathology(Watt and Marcus, 99 
1970). 100 
Thus a novel colitis model in the rabbit that allows to study the mechanisms underlying the 101 
therapeutic effects of T. suis treatment is needed.  102 
In mice and rats experimental colitis is commonly induced by the heparin-like polysaccharide 103 
dextran sodium sulphate (DSS). DSS increases the trans-epithelial permeability by decreasing 104 
the expression, and by inducing the redistribution of tight junction proteins (occludin, zonula 105 
occludens-1, claudins) and by enhancing epithelial cell apoptosis (Poritz, et al., 2007),(Yan, et 106 
al., 2009),(Mennigen, et al., 2009). Furthermore, DSS causes a hyperosmotic stimulus that 107 
leads to the activation of NF-κB in the epithelium (Schwartz, et al., 2008). This is consistent 108 
with the accepted role of epithelial barrier dysfunction in the pathogenesis of IBD (Clayburgh, 109 
et al., 2004). In both IBD and DSS colitis the damaged epithelium allows the entry of luminal 110 
content into the mucosa thereby facilitating the onset of inflammatory processes (Nell, et al., 111 
2010). In mice, short term administration of DSS (1 - 10 % w/v) in drinking water is used to 112 
induce “acute” colitis whereas long-term or cyclic administration produces chronic colitis 113 
(Wirtz, et al., 2007). The development of pathology can be easily monitored based on body 114 
weight, stool appearance, rectal bleeding and behavioural changes. Such clinical changes are 115 
usually preceded by alterations in histopathological parameters including colon shortening, 116 
mucosal injury, immune infiltration and epithelial damage. These changes initially appear in 117 
focal regions of the distal colonic mucosa and then expand progressively although the 118 
inflammation remains confined to the colon (Melgar, et al., 2005).  119 
The DSS model guarantees low risk of mortality, high reproducibility and good uniformity of 120 
the induced mucosal inflammation (Melgar, et al., 2008). We therefore chose to develop a 121 
DSS colitis model in the rabbit. We found that in rabbits, administration of 0.1 % DSS for 122 
five days induces a clear cecum localized inflammation that mimics histological features of 123 
ulcerative colitis and is characterized by a similar gene expression profile as observed in 124 
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biopsies from IBD patients. Furthermore, we describe a scoring system to correlate clinical 125 
parameters with histopathological findings that should facilitate the evaluation of the tested 126 
therapeutic approach.   127 
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Methods 128 
Rabbits 129 
All animal experiments were carried out according to Swiss animal welfare laws and 130 
approved by the veterinary office of Zurich. Female white Himalayan rabbits and New 131 
Zealand white rabbits (Charles River, Kisslegg, Germany) weighing 1.9-2.1 kg were used for 132 
the experiments. Rabbits were maintained single-housed with water and food (standard rabbit 133 
maintenance diet – Provimi Kliba AG, CH-4303 Kaiseraugst-, hay and straw) ad libitum on a 134 
12:12 hour light/dark cycle. Upon arrival, animals were kept for at least 4 days under routine 135 
husbandry. One week prior to DSS exposure, drinking water was substituted by organic 136 
fennel tea (Hipp, Pfaffenhofen, Germany) ad libitum. 137 
Colitis induction and clinical evaluation 138 
Colitis was induced by DSS (MP Biomedicals, Illkirch, France) dissolved in cold fennel tea at 139 
0.1 % w/v (if not specified otherwise). Control rabbits received fennel tea as vehicle. The 140 
beverage was prepared freshly and changed at least every second day. Of every animal daily 141 
weight, daily food and beverage intake, daily stool appearance and behaviour were monitored. 142 
A disease activity index was calculated according to table 1. The disease activity (range: 0-4) 143 
index represents the sum of individual scores for weight loss, presence of uneaten cecotrophs, 144 
food intake and beverage intake divided by 4. Euthanasia was performed following sedation 145 
with barbiturates with an overdose of ketamine hydrochloride (Vétoquinol, Bern, 146 
Switzerland) and xylazine (Bayer, Lyssach, Switzerland). 147 
The abdominal cavity was exposed by a midline laparotomy, and samples were collected from 148 
the ileum, jejunum, duodenum, cecum and colon. For RNA extraction and Myeloperoxidase 149 
activity analysis, the excised samples (0.5 cm in length) from the duodenum, jejunum, ileum 150 
and colon were opened by a longitudinal incision and rinsed with cold PBS. 1 cm2 sections of 151 
the cecum were extensively washed with cold PBS until complete removal of the luminal 152 
content. The samples were immediately snap-frozen in liquid nitrogen, and stored at -80° C 153 
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until analysis. For histological analysis, samples (0.5 cm2 sections of the cecum samples or 0.5 154 
cm length sections of the other tissues) were either cut longitudinally or cut into smaller (0.2 155 
cm) sections for fixation. The samples were carefully washed and fixed with phosphate 156 
buffered 10 % formalin solution. For genome wide mRNA expression studies cecal samples 157 
(2 cm2) were extensively washed with cold PBS and stored on ice in 5 % BSA in PBS until 158 
further processing. 159 
Whole cecal tissue RNA extraction and quantitative real-time PCR 160 
Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany) and the 161 
automated sample preparation system Qiacube (Qiagen, Hilden, Germany) following the 162 
manufacturer's recommendations. cDNA was synthesized with the High-Capacity cDNA 163 
Reverse Transcription Kit (Life Technologies, Carlsbad, California, U.S.A ) 164 
To study the transcription of immune response markers in rabbit intestine tissues, sequence-165 
specific primers were applied (table 2) and q-rtPCR was performed according to Schnupf et 166 
al. with some modifications (Schnupf and Sansonetti, 2012). Amplifications were performed 167 
in a total volume of 15 μl including 50 ng of cDNA, primers (0.2 μM each) and 7.5 ml of 168 
Power SYBR Green mix (Life Technologies, Carlsbad, California, U.S.A). Reactions were 169 
run in triplicate on an ABI 7900HT (Life Technologies, Carlsbad, California, U.S.A ) using 170 
the universal thermal cycling parameters (2 min 54° C, 94.5° C 10 min, 40 cycles of 15 sec at 171 
97° C and 60 sec at 59.7° C; dissociation curve: 15 sec at 95° C, 15 sec at 60° C and 15 sec at 172 
95° C). Results were analysed with the sequence detection software ABI 7900HT SDS2.4. 173 
For quality control purposes all samples’ dissociation curves were acquired and amplification 174 
products were visualized by 2 % agarose gel electrophoresis. Primer sequences are listed in 175 
table 2. The comparative ΔΔCt method was applied for relative gene expression 176 
quantification. (Ct: threshold cycle). 177 
Isolation of cecal lamina propria mononuclear cells (LPMC) and intestinal epithelial cells 178 
(IEC) 179 
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Cecal LPMC and IEC were isolated as previously described (Weigmann, et al., 2007), with 180 
some modifications. Briefly, the dissected mucosa was washed with Ca+- and Mg+-free PBS, 181 
the cecal fold was removed and discarded. The tissue was cut and incubated in medium 182 
containing 20mM EDTA (Sigma-Aldrich) for 30 min at 37° C on a shaking platform (150 183 
rpm). After incubation, the suspension of IECs, villus cells, subepithelial cells and intestinal 184 
epithelial lymphocytes was detached by vortexing and passing through a 70 µm cell strainer 185 
(BD Biosciences, Erembodegem, Belgium). The epithelial cells were washed twice, pelleted, 186 
resuspended in RTL buffer (Qiagen, Hilden, Germany), snap-frozen in liquid nitrogen, and 187 
stored at -80° C for later analysis. The remaining tissue containing LP with muscle layer was 188 
collected and incubated in medium containing 1 μg/ml collagenase type I CLS (Worthington 189 
Biochemical Corp., Freehold, New Jersey, USA) at 37° C on a shaking plate (300rpm). After 190 
15 minutes incubation, the suspension was vortexed and filtered through a 70 µl strainer. The 191 
filtered cells were resuspended in 5 % BSA in PBS to stop the enzymatic digestion. The 192 
undigested tissue was incubated with fresh collagenase solution for additional 15 minutes. 193 
The collagenase digestion was repeated three times and the washed LPMC were pooled. LPC 194 
were pelleted twice and resuspended in DMEM supplemented with 5 % FCS. LPMC were 195 
purified using Ficoll-Paque PLUS (GE Healthcare Europe GmbH, Freiburg Germany) 196 
gradient centrifugation for 40 min at 1200 rpm. The viability of the cells was confirmed by 197 
tryptan blue staining. Cells were resuspended in RTL buffer (Qiagen, Hilden, Germany), 198 
snap-frozen in liquid nitrogen, and stored at -80° C for later analysis. 199 
RNA isolation and genome wide mRNA expression analysis 200 
Total RNA was isolated with the Qiacube system using the RNeasy Mini Kit with DNase 201 
digestion (Qiagen, Hilden, Germany) to eliminate genomic DNA. RNA integrity and quantity 202 
was determined on the Agilent 2100 Bioanalyzer (Agilent; Palo Alto, CA, USA). Samples 203 
with an integrity score ≥ 6.8 were sent to the Functional Genomic Centre Zurich (FGCZ) for 204 
sequencing on the Illumina® platform. The fold change (FC) was used to express the changes 205 
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in average gene expression between studied groups. FC was normalized against the control 206 
group (rabbits receiving fennel tea only). The ENSEMBLE IDs were annotated using 207 
BetterBunny augmented annotation and analysis of rabbit genes 208 
(http://cptweb.cpt.wayne.edu)(Craig, et al., 2012). MetaCore™ (Thomson Reuters, 209 
http://portal.genego.com) was used to perform network and pathway analyses. The following 210 
cut-offs were applied to select differentially expressed genes for further analysis: pValue p ≤ 211 
0.01 and fold change ≥ |2.0|. The pathways (groups of genes belonging to the same pathway 212 
map in MetaCore™ database) and gene families were considered significant with a pValue ≤ 213 
0.05 and were further selected on the basis of their relevance to inflammatory bowel diseases 214 
pathology. Additional gene expression data sets for comparison were obtained from GEO 215 
DataSets (NCBI) of previously published studies in colon pinch biopsies from UC and CD 216 
patients (Granlund, et al., 2013). 217 
Validation of the genome wide mRNA expression analysis 218 
The expression profiling results were confirmed by qPCR of selected genes involved in the 219 
highlighted pathways. cDNA synthesis was performed using a High-Capacity cDNA Reverse 220 
Transcription Kit (Life Technologies Ltd). Real-time PCR was performed using TaqMan 221 
Gene Expression Assays (Life Technologies Ltd) and TaqMan Fast Universal PCR Master 222 
Mix No AmpErase UNG (Life Technologies Ltd) on a 7900 HT Fast Real-Time PCR System 223 
with SDS 2.2 Software (Life Technologies Ltd). TaqMan gene expression assays were 224 
performed for COX-2 (Ptgs2, Oc03398293_m1), IL-6 (Oc04097051_m1), MMP-1 225 
(Oc04250656_m1) and the housekeeping gene GAPDH (Oc03823402_g1) as an endogenous 226 
control. Measurements were performed in triplicates; relative expression was calculated using 227 
the ΔΔCt method. 228 
Histopathological evaluation of colitis 229 
After careful dissection and fixation, tissues were routinely embedded in paraffin. Serial 230 
sections of 5 μm were cut using a microtome (Carl Zeiss AG, Feldbach, Switzerland) and 231 
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stained with haematoxylin-eosin to investigate epithelial damage and cellular infiltration. The 232 
histological changes in the cecum were quantified in a blinded manner by two investigators 233 
with a scoring system (range 1 - 24) for morphological features and infiltration of immune 234 
cells according to the scoring system described in table 3 (Kojouharoff, et al., 1997),(Cooper, 235 
et al., 1993),(Day, et al., 2008). 236 
Analysis of myeloperoxidase activity  237 
MPO activity was measured in different regions of the gastrointestinal tract as previously 238 
described. MPO activity was calculated as mean absorbance (460 nm) per incubation time per 239 
protein content of the sample in grams (indicated as arbitrary units U/g.s)(Bozeman, et al., 240 
1990) 241 
Statistical analysis 242 
The results of the 0.1 % DSS colitis were obtained in two different experiments (n = 8 and n = 243 
4). As the experimental protocol was identical for both experiments results were pooled 244 
together. The data obtained from this study was analysed using IBM-SPSS statistic 21. The 245 
majority of the examined parameters were asymmetrically distributed. For the comparison of 246 
the treatment groups the non-parametric Mann - Whitney U-test for two independent samples 247 
was used.   248 
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Results  249 
Clinical symptoms of DSS exposure in rabbits 250 
Since rabbits have a more sensitive digestive tract in comparison to mice, the concentration of 251 
DSS to induce colitis had to be drastically decreased. We observed a reduction of daily 252 
beverage intake that we ascribed to the unpleasant taste of DSS. To overcome this problem, 253 
DSS was dissolved in organic fennel tea that successfully masked the taste of the DSS and 254 
restored a normal beverage intake during DSS exposure. 255 
A pilot study (data not shown) showed that administration of 0.1 % DSS in fennel tea for 3 256 
days reduced the normal weight gain from day 5 on in the treated animals. This effect was no 257 
longer present from day 14 on indicating a restitution of the colitis. Other clinical symptoms 258 
were not evident. Histological analysis of HE stained intestinal samples showed no clear signs 259 
of inflammation; only a slight reduction in the number of goblet cells in the cecum at day 7 260 
and 10 was observed. Subsequently, the duration of the DSS phase was increased from 3 to 5 261 
days. 12 white Himalayan rabbits were fed for 5 days with 0.1 % DSS in the daily beverage 262 
(fennel tea), whilst control rabbits (n = 5) housed in the same facility were given fennel tea 263 
without DSS. The earliest symptoms manifested at day 4, when the rabbits started to 264 
gradually diminish the daily food and beverage intake from the initial 120 g/day pellet and 265 
210 ml/day beverage intake at day 1 down to 40 g/day and 100 ml/day at day 7 (figure 1 A, 266 
B).  267 
Exposure to 0.1 % DSS markedly reduced the weight gain (figure 1 C). Further symptoms 268 
included the presence of loose and smeared stool (figure 1 D), behavioural abnormalities such 269 
as apathy or aggressiveness and unclean fur. A combinatorial index of disease, (figure 1 E, 270 
disease activity index DAI, described in the methods section) was used to quantify the 271 
severity of the monitored clinical symptoms. We found that whilst the DAI of control rabbits 272 
remained at baseline (DAI < 0.5), the DAI of rabbits receiving DSS increased significantly 273 
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starting from day 5 (DSS: 0.47 ± 0.32, n = 12; control: 0.08 ± 0.10. n = 5) and rose up to 2.1 274 
at day 12. 275 
DSS induces a cecum localized pathology 276 
Histological evaluation of the intestinal tract revealed a cecum localized pathology, whereas 277 
no clear signs of tissue damage were observed in other regions of the intestinal tract (colon 278 
and ileum, figure 2).  279 
Histopathology of the cecum was characterized by infiltration of immune cells into the 280 
epithelial layer and the lamina propria and by morphological changes such as villous stunting, 281 
crypt distortion and villous epithelial injury (figure 3 a, c, d). The global histology score was 282 
increased from day 4 onward (figure 3b). The severity of the damage increased progressively 283 
even after the removal of DSS from a baseline value of 7.7 ± 0.9 in control rabbits (n = 5) to 284 
an average score of 13.3 ± 5.0 at day 10 (n = 4) and further increased until day 14.  285 
Expression analysis of genes involved in the immune response 286 
To evaluate the inflammatory response in DSS treated rabbits, we analysed the mRNA 287 
expression of inflammation related genes by q-rtPCR. iNOS, IFNγ and IL-12 p35 were 288 
chosen as they have been implicated in IBD and have been shown to be overexpressed in 289 
inflamed rabbit tissue(Schnupf and Sansonetti, 2012). Gene expression analysis of 290 
inflammatory markers in the cecum showed a transient increase of IL-12 p35 in DSS treated 291 
rabbits (figure 4), although, owing to the limited sample number in the control group, the 292 
difference did not reach statistical significance. No difference between the groups was 293 
observed for iNOS and IFNγ.  294 
Genome wide gene expression analysis in LPMC and IEC by RNAseq  295 
Genome wide gene expression analysis identified 470 differentially expressed genes in IECs 296 
and 215 differentially expressed genes in LPMCs (FC ≥ |2|, p ≤ 0.05). The process networks 297 
that were significantly over-represented in the MetaCore™ analysis were 58 in LMPCs and 298 
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49 in IECs, respectively. Among the most relevant process networks, there was an 299 
overrepresentation of genes involved in inflammation, immune response and chemotaxis 300 
(figure 5). 301 
Furthermore, the diseases (by biomarkers) ontology in MetaCore™ was used to assess the 302 
similarity between the gene expression in our rabbit DSS colitis model with the gene 303 
expression known to be associated with selected human diseases. In both LPMC and EC we 304 
found an enrichment of differentially expressed genes associated with inflammation, IBD, CD 305 
and UC (figure 6). 306 
To further confirm the results of the disease enrichment analysis we compared genes 307 
differentially regulated in our DSS colitis model with a gene set from a genome wide gene 308 
expression analysis in human CD and UC patients(Granlund, Flatberg, Ostvik, Drozdov, 309 
Gustafsson, Kidd, Beisvag, Torp, Waldum, Martinsen, Damas, Espevik and Sandvik, 2013). 310 
Overall, the majority of the differentially expressed genes were involved in immune response, 311 
cell adhesion, cytoskeleton reorganization and chemokine signalling (figure 4; table 5).  312 
Finally, the sequencing results for mRNA expression were exemplarily validated for COX-2, 313 
IL-6 and MMP1 by qPCR (figure 7). In accordance with our transcriptome results the 314 
expression of the selected genes was higher in both LPMC and EC cells isolated from DSS 315 
treated rabbits in comparison to the non colitic controls. 316 
 317 
DSS transiently increases neutrophil infiltration in the rabbit cecum 318 
The neutrophil infiltration into inflamed tissues was monitored by analysis of 319 
myeloperoxidase (MPO) activity (Bradley, et al., 1982). MPO activity in the cecum of DSS 320 
treated rabbits transiently increased at day 5-7 before returning to baseline levels at day 14 321 
(figure 8 a), due to the low number of animals the change did not reach statistical 322 
significance. Analysis of MPO in the ileum and the colon showed no significant differences 323 
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between colitis animals and the control group (figure 8 b,c). In the ileum, the basal MPO 324 
activity in untreated rabbits was higher than in the cecum but no changes occurred upon 325 
exposure to DSS. Overall, our results suggest that the DSS induced infiltration of neutrophils 326 
predominantly localizes in the cecum.  327 
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Discussion 328 
The helminth parasite T. suis has shown promising results for the treatment of IBD in human 329 
studies. Unfortunately, efficacy and safety (in particular in immune-compromised subjects) as 330 
well as the underlying mechanisms cannot be studied in the well-established mouse and rat 331 
models of IBD since the parasite’s ova fail to hatch in the intestine of these rodents. T. suis 332 
ova (TSO) hatch in pig (the natural host), men, and rabbits. Since the life cycle of T. suis in 333 
human and in rabbits appears similar, a rabbit model of colitis would represent an adequate 334 
model for investigations into TSO therapy. The aim of the present study was to develop an 335 
IBD model in rabbits by administration of dextran sodium sulphate (DSS) in the daily 336 
beverage. This study shows that administration of 0.1 % DSS for 5 days is sufficient to induce 337 
a clear acute inflammation that is localized in the cecum. Localization of the pathology in the 338 
cecum makes the DSS model particularly suitable to study the effects of T. suis ova (TSO) 339 
treatment as the cecum is the site of T. suis colonization in rabbits. 340 
In accordance with the disease manifestation in other species, the clinical symptoms observed 341 
in rabbits were reduced weight gain, reduced food and beverage intake, loose stools and 342 
unclean fur(Wirtz, Neufert, Weigmann and Neurath, 2007). The strong reduction in liquid 343 
intake began after five days, only, hence the daily intake of DSS remained constant 344 
throughout the whole induction phase.  345 
The reduction in food intake reflects the response to abdominal discomfort and the 346 
disturbances in feeding behaviour that are seen in patients with inflammation of the 347 
gastrointestinal tract(Rigaud, et al., 1994) and are also commonly observed in mouse and rat 348 
models of gastrointestinal inflammation(McHugh, et al., 1993),(McDermott, et al., 2006). To 349 
facilitate the evaluation of the disease outcome we developed a disease activity index (DAI) 350 
based on the monitoring of the different clinical parameters. Starting from day 4 after DSS 351 
administration, rabbits manifested clear symptoms of pathology that gradually worsened and a 352 
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peak of disease activity was reached at day 9. Afterwards, the DAI decreased and stabilized 353 
until the last analysed time point at day 14. 354 
Macroscopical analysis of the internal organs following euthanasia showed no abnormalities. 355 
In contrast, histopathological analysis of the intestinal tract revealed that DSS causes an 356 
inflammation predominantly localized in the cecum. The other sections of the large intestine 357 
and the small intestine remained unaffected. 358 
The cecum localization of the DSS induced inflammation is also observed in guinea pigs and 359 
in the Mongolian gerbil model(Iwanaga, et al., 1994),(Bleich, et al., 2010). These species 360 
possess a functional cecum that is particularly enlarged and provides a niche for the microbial 361 
fermentation of cellulose(Snipes, 1982),(Snipes, 1997). The cecum localization of the DSS 362 
induced inflammation might be due to an increased permeability of the intestinal barrier to 363 
DSS in this particular section of the intestine(Hoshi, et al., 1996). The localization of the 364 
lesions in gerbils has been linked to the increased absorption of sulphated polysaccharides in 365 
this particular section of the gerbil intestine and absorption of DSS in the cecum has also been 366 
reported in rabbits(Sharratt, et al., 1971) and might explain our observations. In accordance 367 
with DSS models in other species, DSS treatment induced both a disruption of the mucosal 368 
morphology and an infiltration of immune cells (Melgar, Karlsson and Michaelsson, 2005). In 369 
particular, the histopathology of the cecum displays crypt loss, epithelial damage and 370 
infiltration of immune cells. These manifestations reproduce characteristic traits commonly 371 
observed in ulcerative colitis(Okayasu, et al., 1990). Despite the progressive amelioration of 372 
the clinical symptoms after their peak at day 9, the histological damage persists longer and 373 
displays some characteristics of chronic intestinal inflammation such as the atypical branching 374 
of the crypts. 375 
The initial pathology (day 4 - 9) presents classical features of an acute inflammation. From 376 
day 7 to day 10, we observe a transient increase of neutrophil infiltration into the cecal 377 
mucosa accompanied by an increased expression of the pro-inflammatory cytokine IL-12 p35. 378 
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This transient inflammatory activity correlates well with the peak of the DAI and with the 379 
histological findings and suggests an initial T helper 1 driven acute response. The increased 380 
neutrophil activity in the cecal mucosa is a common feature with the guinea pig colitis model. 381 
However, the described model in guinea pigs was performed with high concentration of DSS 382 
(3 %) and had a fulminant outcome, with 96 % of the animals dying within 96 h (Iwanaga et 383 
al., 1994a). 384 
Genome wide mRNA expression profiling in cecum LPMCs and ECs at day 10 showed an 385 
enrichment of genes involved in chemotaxis and immune response. In particular, the immune 386 
response was characterized by genes involved in Th17 signalling, particularly in epithelial 387 
cells. An activation of the innate immune response is a feature shared by both CD and UC 388 
patients. In contrast, Th17-associated cytokines are usually observed in the inflamed mucosa 389 
of CD patients, only. Our analysis further showed enrichment for IL-4 related cytokines that 390 
would rather suggest a Th2 type response. This type of response correlates well to the atypical 391 
Th2 response (mediated by natural killer cells producing IL-13) observed in UC patients 392 
(Fuss, et al., 2004). A switch into a Th2 type response has been observed as the colitis 393 
matures from an acute toward a chronic phase (Alex, et al., 2009). The features that appear at 394 
later stages of the rabbit colitis might indicate that after an acute phase characterized by 395 
severe clinical symptoms, mucosal damage and acute inflammation, the pathology acquires a 396 
certain degree of chronicity with a shift toward a Th12 immune response. A long-term 397 
analysis is necessary to investigate these preliminary observations and to clarify if the disease 398 
resolves after the acute phase or if it progresses to chronicity. 399 
In summary, we report the development and characterization of a novel DSS induced colitis 400 
model in rabbits. The initial pathology has an acute nature and is characterized by specific 401 
clinical symptoms, histopathological changes and higher mRNA expression of inflammatory 402 
markers. Our model provides a safe and reliable induction of colitis in rabbits that is 403 
particularly suitable to study the effects and mechanisms of TSO treatment in IBD.  404 
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Figure legends 547 
 Figure 1: Manifestation of clinical symptoms upon DSS exposure. Response to colitis 548 
induction was monitored daily according to a detailed score sheet. Food intake (a), beverage 549 
intake (b), weight change (c), stool consistency (d. representative pictures for control and DSS 550 
rabbits at day 10) were summarized into a disease activity index (e. DAI, 0-4). DSS rabbits 551 
(●, n = 12) were fed with 0.1 % DSS in the daily beverage (fennel tea) for 5 days. The control 552 
group (○, n = 5) was maintained under the same conditions with fennel tea as beverage. Data 553 
represent mean ± SD; Mann Whitney Test, ** p ≤ 0.005, * p ≤ 0.05. 554 
 555 
Figure 2: Absence of histopathology in the colon and ileum. Representative HE stained colon 556 
(A) and ileum (B) sections in control and in DSS exposed rabbits at day 10. Scale: 200 μm. 557 
 558 
Figure 3: Histopathological changes of the cecum at different time points after colitis 559 
induction. HE stained cecum sections were scored (A, 1 - 4) for markers of inflammation 560 
(infiltration of lamina propria eosinophils, lamina propria lymphocytes, intraepithelial 561 
lymphocytes) and for the distortion of morphological features (villous stunting, villous 562 
epithelial injury, crypt distortion) . Single parameters were summarized to a global score (B). 563 
Black dots represent DSS treated rabbits (●); white dots represent control rabbits (○). 564 
Horizontal lines represent the arithmetical mean; Mann Whitney Test, ** p ≤ 0.05, * p ≤ 0.1.   565 
Representative HE stained cecal sections of control rabbits (C) and of DSS exposed rabbits at 566 
different time points after colitis induction (D). Scale: 200 μm. 567 
 568 
Figure 4: mRNA expression of pro-inflammatory cytokines during colitis induction. mRNA 569 
expression of IL-12 p35 in cecum from DSS treated (●) or control (○) rabbits. Results are 570 
shown as mean expression relative to GAPDH using the 2− ΔΔCt method. Dots represent 571 
single animals, each sample was analyzed in triplicate and data are expressed as mean ± SE. 572 
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 573 
Figure 5: Process network analysis of differentially expressed genes in epithelial cells (EC, 574 
black bars and line) and lamina propria mononuclear cells (LPMC, grey bars and line). This 575 
analysis is based on a manually curated database of process networks, which details more 576 
specific biological processes than GO annotations alone. Most prominent process networks 577 
associated with the identified genes were involved in cell adhesion and chemotaxis (═) and 578 
immune and immune responses (▬). Analysis was performed with MetaCoreTM. Bars 579 
represent the Log(p-Value) of enriched pathways, whereas lines represent the ratio between 580 
differentially expressed genes upon DSS exposure and the total number of genes involved in 581 
the specific process network. Gene expression threshold: fold change ≥ |2.0|; p-Value ≤ 0.05. 582 
 583 
Figure 6: Enrichment of differentially expressed genes in selected disease categories (by 584 
biomarkers) in epithelial cells (IEC, white bars and line) and lamina propria mononuclear 585 
cells (LPMC, grey bars and line). The Gene IDs of the orthologous genes assigned to the 586 
differentially expressed rabbit mRNAs were analysed for enrichment in selected disease 587 
categories using MetaCore™. Terms relevant for IBD and experimental colitis are displayed. 588 
Bars represent the Log(p-Values) of enriched pathways, whereas lines represent the ratio 589 
between the differentially regulated genes upon DSS exposure and the total number of genes 590 
involved in the specific process network. IBD, inflammatory bowel disease, UC, ulcerative 591 
colitis, CD, Crohn’s disease. Gene expression threshold: fold change ≥ |2.0|; p-Value ≤ 0.05. 592 
 593 
Figure 7: Quantitative RT-PCR showing expression of COX-2 (A, D), IL-6 (B, E) and MMP-594 
1 (C, F) in intestinal epithelial cells (IEC, upper panel) and lamina propria mononuclear cells 595 
(LPMC, lower panel) of DSS and control rabbits at day 10 post colitis induction. Expression 596 
is shown relative to gapdh in the distal colon, n = 4–9. Values are given as mean ± SD and 597 
difference between groups was tested by two-tailed Student’s t test. 598 
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 599 
Figure 8: Myeloperoxidase (MPO) was determined as a marker for neutrophil infiltration in 600 
the gastrointestinal epithelium. Values for MPO activity in cecum (A), duodenum (B) and 601 
ileum (C) samples were normalized for the total protein concentration as determined by BCA 602 
assay and for the incubation time (values are represented in arbitrary units U/g.s). Dots 603 
represent single animals. 604 
  605 
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Table 1: Scoring system for the daily monitoring of the disease activity index. 
Score weight loss 
stool appearance and 
cecotrophs 
reduction in food 
intake 
reduction in 
beverage intake 
fur appearance 
0 None well-formed solid pellets, 
0 cecotrophs 
none none clean, bright 
fur 
1 0-2 % easy to smear and loose stool, 
≤1 cecotrophs 
0-30 % 0-30 % dim fur 
2 2-5 % loose stool, 
2-3 cecotrophs 
30-60 % 30-60 % shagged fur 
3 5-10 % loose smeared stool in cage, 
4-5 cecotrophs 
60-90 % 60-90 % smudgy, 
unclean fur 
4 > 10 % loose smeared stool in cage, 
> 5 cecotrophs 
> 90 % > 90 % smudgy, stool-
stains, smeared 
anus 
 606 
  607 
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Table2: Primers for qPCR 
Marker 
Forward primer 
Backward primer 
Primer location 
within CDS 
Target size 
NCBI 
Accession  
IL-12p35 AAGGCCAGACAAACTCTAGAATTC 
TTGGTTAACTCCAGTGGTAAACAGG 
Exon 3/4 and 4/5 
from ∼8 
116 nts XM_002716291 
iNOS GACGTCCAGCGCTACAATATCC 
GATCTCTGTGACGGCCTGATCT 
Undetermined 102 nts XM_002718780 
IFNγ TGCCAGGACACACTAACCAGAG 
TGTCACTCTCCTCTTTCCAATTCC 
Exon 1 and 2/3 from 
4 
127 nts NM_001081991 
GAPDH TGACGACATCAAGAAGGTGGTG 
GAAGGTGGAGGAGTGGGTGTC 
Exon 1 of 1 120 nts NM_001082253 
 608 
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Table 3: Scoring system for DSS-induced histological changes in the cecum. 
 Morphological features  Inflammation 
 
Villous 
stunting 
Villous 
epithelial 
injury 
Crypt 
distortion 
 
Intraepithelial 
lymphocytes 
LP lymphocytes 
and plasma cells 
LP 
eosinophils 
1 Normal 
mucosa 
Normal 
mucosa 
Normal 
mucosa 
 5–10/50 
IEL/epithelial 
cells 
25 % of the 
villous lamina 
propria 
2–3 cells per 
× 40 field 
2 Mild villous 
stunting 
Mild 
villous 
epithelial 
injury 
Mild crypt 
distension, 
hyperplasia 
and distortion 
 11–30 IEL/50 
epithelial cells. 
25–50 % of the 
villous lamina 
propria 
5 -10 per × 
40 field. 
3 Moderate 
villous 
stunting 
Moderate 
villous 
epithelial 
injury 
Moderate 
crypt 
distension, 
hyperplasia 
and distortion. 
 31–50 IEL/ 50 
epithelial cells 
may be focally 
clustered. 
50–75 % of the 
villous lamina 
propria. 
10 - 20 per 
× 40 field. 
4 Marked 
villous 
stunting 
Marked 
villous 
epithelial 
injury 
 
Marked crypt 
distension, 
hyperplasia 
and distortion 
 51–100 IEL/ 50 
epithelial cells, 
may be clustered 
and at all levels of 
the epithelium 
75 – 100 % of the 
villous lamina 
propria. 
> 20 per × 
40 field 
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Table 4: Genes concordantly up-regulated in LPMCs of DSS colitis 
rabbits and IBD biopsies. 
Cell adhesion and Cytoskeleton reorganization Metabolism and biosynthesis 
CD38 PTGS2(COX2) 
PLEK SLC6A14a 
S100A9 TCN1 
SELLa  
Cytokine and Cytokine R genes Development 
IL1A EGR2a 
IL6  
IL8  
IRF1  
Chemokine and Chemokine R genes Tissue remodelling Genes 
CCR7a MMP3 
CXCL10  
CXCL11  
CXCR4  
ENA-78a  
Immune response  
Innate Immune defence BCR and TCR signalling 
TMEM173 CD19 
DMBT1 LAX1 
FAM65Ba  
SLC11A1a  
List of genes concordantly up-regulated in LPMC from the cecum of DSS treated rabbit and 
colonic biopsies of inflamed tissue from IBD patients. LPMC: Lamina propria mononuclear 
cells. adifferentially expressed in UC patients, only. 
  611 
30 
 
 
 
 612 
Table 5: Genes concordantly up-regulated in ECs of DSS colitis rabbits 
and IBD biopsies. 
Cell adhesion and Cytoskeleton reorganization Metabolism and biosynthesis 
SELLa FCRLA b 
PLEK PLA2G7a 
VNN1 SLC11A1a 
S100A9 SLC2A3 
CLEC4A SLC6A14a 
CD38 TCN1 
Cytokine and Cytokine R genes Apoptosis 
IL1A UBD 
IL1B IER3a 
IL6a PEA15a 
IL8  
Chemokine and Chemokine R genes Cell-cell signalling 
CCR7a ADM 
CXCL10 TNFAIP6a 
CXCL11 Tissue remodelling Genes 
CXCL13 CTSK 
CXCL5a MMP1 
CXCL6 MMP12 
CXCL9 SERPINE2 
Immune response  
Innate immune defence BCR and TCR signalling 
OAS2 CD19 
TLR8 b CD74 
Humoral immune response CD79B 
POU2AF1 CD86a 
CD83a LYNa 
Acute-phase response SLAMF8a 
31 
 
 
 
SERPINA1 inflammatory response 
Antigen processing NFKBIZa 
HLA-DMA anti-inflammatory response  
HLA-DPA1 A1F1 
HLA-DPB1b  
List of genes concordantly up-regulated in EC from the cecum of DSS treated rabbit and 
colonic biopsies of inflamed tissue from IBD patients. EC: epithelial cells. agenes 
differentially expressed in UC patients, only. bgenes differentially expressed in CD 
patients, only. 
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